Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
In this trial, the potential anti-epileptic effect of low dose fenfluramine in Lennox Gastaut
epilepsy will be studied. An exploratory dose finding add-on trial is proposed. At baseline
and at the end of the study, ECG and ultrasound of the heart will be performed as part of the
safety follow up.